Quarterly report · Q1
2150.TEDINET S100TFC8
Period2024-01-01 → 2024-03-31
Filed2024-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.7bn | 2024-01-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥10.2bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.5bn | 2023-01-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥545m | 2024-01-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥715m | 2023-01-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥564m | 2024-01-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.5bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥716m | 2023-01-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥516m | 2024-01-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥716m | 2023-01-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥311m | 2024-01-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥458m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥330m | 2024-01-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥464m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥13.5bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥14.2bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥12.4bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.3bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥2.7bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥11.2bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥11.5bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥10.2bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.0bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.9bn | at 2023-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥6.98 | 2024-01-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.9 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.27 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 81.7% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.3% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 25
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-03-31 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-03-31 | −¥2m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-03-31 | −¥423m |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥2.4bn |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥2.4bn |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥1m |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥946m |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥266m |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥265m |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥500,000 |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥23m |
| —segment total | revenue | 2024-01-01 → 2024-03-31 | ¥2.7bn |
| —segment total | revenue external | 2024-01-01 → 2024-03-31 | ¥2.7bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥2m |
| —segment total | segment profit | 2024-01-01 → 2024-03-31 | ¥968m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-03-31 | −¥336m |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥2.3bn |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥2.3bn |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥985m |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥227m |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥227m |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥66m |
| —segment total | revenue | 2023-01-01 → 2023-03-31 | ¥2.5bn |
| —segment total | revenue external | 2023-01-01 → 2023-03-31 | ¥2.5bn |
| —segment total | segment profit | 2023-01-01 → 2023-03-31 | ¥1.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 334
| Item | Context | Value | Unit |
|---|---|---|---|
| Finished goods | CurrentQuarterInstant | 6793000 | JPY |
| Work in process | Prior1YearInstant | 25747000 | JPY |
| Work in process | CurrentQuarterInstant | 25467000 | JPY |
| Supplies | Prior1YearInstant | 1484000 | JPY |
| Supplies | CurrentQuarterInstant | 1304000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E05684-000MedicalDigitalTransformationBusinessReportableSegmentsMember | 2299660000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E05684-000MedicalPlatformBusinessReportableSegmentsMember | 227054000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 2526715000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 2526715000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E05684-000MedicalDigitalTransformationBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E05684-000MedicalPlatformBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E05684-000MedicalDigitalTransformationBusinessReportableSegmentsMember | 2299660000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E05684-000MedicalPlatformBusinessReportableSegmentsMember | 227054000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 2526715000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 2526715000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E05684-000MedicalDigitalTransformationBusinessReportableSegmentsMember | 985033000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E05684-000MedicalPlatformBusinessReportableSegmentsMember | 65690000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 1050723000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -335663000 | JPY |
| Operating income | Prior1YTDDuration | 715060000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E05684-000MedicalDigitalTransformationBusinessReportableSegmentsMember | 2401748000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E05684-000MedicalPlatformBusinessReportableSegmentsMember | 265400000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 2667149000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 2667149000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E05684-000MedicalDigitalTransformationBusinessReportableSegmentsMember | 1400000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E05684-000MedicalPlatformBusinessReportableSegmentsMember | 500000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 1900000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -1900000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E05684-000MedicalDigitalTransformationBusinessReportableSegmentsMember | 2403148000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E05684-000MedicalPlatformBusinessReportableSegmentsMember | 265900000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 2669049000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -1900000 | JPY |
| Net sales | CurrentYTDDuration | 2667149000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E05684-000MedicalDigitalTransformationBusinessReportableSegmentsMember | 945623000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E05684-000MedicalPlatformBusinessReportableSegmentsMember | 22701000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 968325000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -423074000 | JPY |
| Operating income | CurrentYTDDuration | 545251000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-05-14 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第30期第１四半期（自 2024年１月１日 至 2024年３月31日） |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |